Published in Gene Therapy Weekly, August 28th, 2003
In experiments with mice destined to develop the condition, injection of the gene for insulin-like growth factor-1 (IGF-1) into muscles protected nerve cells, extended survival and improved strength, said the scientists, who are planning a clinical trial they hope to be able to begin in the next year.
The current study was published in the August 8, 2003, issue of Science.
The most beneficial treatment ever seen...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.